20xx年醫(yī)學(xué)專題—上肢深靜脈血栓研究進展-免費閱讀
【正文】 Merminodet al,2006, Switzerland：。)CVC置入 小劑量低分子肝素、小劑量華法林、維生素K拮抗劑（繼發(fā)性）,第二十七頁，共二十九頁。li225。i)濾器,Owens C A, Bui J T, Knuttinen M G, et al. Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature[J]. J Vasc Interv Radiol,2010,21(6):779787,上腔靜脈(j236。,抗凝,ACCP建議(ji224。,第十七頁，共二十九頁。c232。,臨床(l237。i)血栓： 遺傳性血栓形成傾向：蛋白C、蛋白s或抗凝血酶、凝血因子Ⅲ缺乏，凝血因子VLeiden突變和凝血酶原G20210A突變 解剖結(jié)構(gòu)異常：PagetSchroetter綜合征 Grant, J.D., et al., Diagnosis and management of upper extremity deepvein thrombosis in adults. Thromb Haemost, 2012.,第六頁，共二十九頁。 x237。ngzhī)深靜脈血栓 upper extremity deep venous thrombosis UEDVT,第一頁，共二十九頁。i)危險因素的深靜脈血栓形成，約占80% Cuc Mai, M.D.H.M.,Upper extremity Deep Venous Thrombosis A Review. The American Journal of Medicine, 2011.,第二頁，共二十九頁。),Spencer F A E C L D. Upper Extremity Deep Vein Thrombosis A CommunityBased[J]. Am J Med,2007,8(120):678684. Hylton V. Joffe N K V F. UpperExtremity
環(huán)評公示相關(guān)推薦
鄂ICP備17016276號-1